Back to funds

Boxer Capital Management, LLC

Updated 6 days ago

Managed by Boxer Capital Management, Llc • Latest filing Q3 2026

Portfolio value
$1.2B
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 7 quarters

Show data table
PeriodPortfolio value
Q1 2025$332.5M
Q2 2025$198.7M
Q3 2025$313.7M
Q4 2025$456.9M
Q1 2026$761.7M
Q2 2026$1.3B
Q3 2026$1.2B

Top holdings

47 positions as of Q3 2026

View filing
T

TANGO THERAPEUTICS INC

Value
$262.6M
Shares
10.53M
% Port
22.82%
K

KODIAK SCIENCES INC

Value
$140.1M
Shares
1.48M
% Port
12.17%
R

REVOLUTION MEDICINES INC

Value
$102.6M
Shares
500.0K
% Port
8.92%
K

KYMERA THERAPEUTICS INC

Value
$58.6M
Shares
524.6K
% Port
5.10%
Q

REPLIMUNE GROUP INC

Value
$56.6M
Shares
4.28M
% Port
4.92%
A

ABIVAX SA

Value
$47M
Shares
475.0K
% Port
4.09%
S

SURROZEN INC

Value
$43.8M
Shares
1.36M
% Port
3.81%
C

CORCEPT THERAPEUTICS INC

Value
$38.7M
Shares
335.5K
% Port
3.36%
P

PRECIGEN INC

Value
$37M
Shares
4.32M
% Port
3.21%
Q

UNIQURE NV

Value
$34.4M
Shares
1.42M
% Port
2.99%
D

DEFINIUM THERAPEUTICS INC

Value
$26M
Shares
683.6K
% Port
2.26%
A

AMYLYX PHARMACEUTICALS INC

Value
$26M
Shares
893.2K
% Port
2.26%
S

SPYRE THERAPEUTICS INC

Value
$25.2M
Shares
283.1K
% Port
2.19%
P

PROTAGONIST THERAPEUTICS INC

Value
$24M
Shares
170.0K
% Port
2.08%
C

CELCUITY INC

Value
$22.8M
Shares
286.2K
% Port
1.98%
I

OPUS GENETICS INC

Value
$21.9M
Shares
4.53M
% Port
1.91%
Q

Q32 BIO INC

Value
$21.3M
Shares
2.58M
% Port
1.85%
U

UROGEN PHARMA LTD

Value
$20.3M
Shares
500.0K
% Port
1.77%
A

ACHIEVE LIFE SCIENCE INC

Value
$17.4M
Shares
2.15M
% Port
1.51%
B

C4 THERAPEUTICS INC

Value
$13.8M
Shares
4.15M
% Port
1.20%

Explore